These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 31306487

  • 1. Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.
    Jarkvist J, Salehi C, Akin C, Gülen T.
    Allergy; 2020 Jan; 75(1):169-177. PubMed ID: 31306487
    [Abstract] [Full Text] [Related]

  • 2. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P, Zanotti R, Pagani M, Bonifacio M, Scaffidi L, Olivieri E, Franchini M, Reccardini F, Costantino MT, Roncallo C, Mauro M, Boni E, Rizzini FL, Bilò MB, Marcarelli AR, Passalacqua G.
    J Allergy Clin Immunol Pract; 2018 Jan; 6(4):1368-1372. PubMed ID: 29258788
    [Abstract] [Full Text] [Related]

  • 3. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M, Oldhoff JM, Klemans RJ, Lahey-de Boer A, de Bruin-Weller MS, Röckmann H, Sanders C, Bruijnzeel-Koomen CA, Pasmans SG, Knulst AC.
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [Abstract] [Full Text] [Related]

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Nov; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW, Meusser-Storm S, Eger G.
    Allergol Immunopathol (Madr); 2005 Nov; 33(1):7-14. PubMed ID: 15777517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [Abstract] [Full Text] [Related]

  • 9. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C, Mauro M, Gritti BL, Makri E, Ridolo E.
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [Abstract] [Full Text] [Related]

  • 10. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 11. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fatal anaphylactic sting reaction in a patient with mastocytosis.
    Wagner N, Fritze D, Przybilla B, Hagedorn M, Ruëff F.
    Int Arch Allergy Immunol; 2008 Oct 17; 146(2):162-3. PubMed ID: 18204283
    [Abstract] [Full Text] [Related]

  • 14. Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.
    Bonadonna P, Scaffidi L.
    Immunol Allergy Clin North Am; 2018 Aug 17; 38(3):455-468. PubMed ID: 30007463
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F, Boquete M, Núñez R, Lombardero M, de la Torre F.
    J Investig Allergol Clin Immunol; 2010 Aug 17; 20(6):506-13. PubMed ID: 21243935
    [Abstract] [Full Text] [Related]

  • 20. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y, Nashef F, Cohen-Engler A, Meir-Shafrir K, Lachover-Roth I, Confino-Cohen R.
    Int Arch Allergy Immunol; 2019 Aug 17; 180(2):128-134. PubMed ID: 31216540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.